Loading...

PE anti-mouse CD8a Antibody PE anti-mouse CD8a Antibody

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_53-6dot7_PE_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) PE (filled histogram) or rat IgG2a, κ PE isotype control (open histogram).
  • 1_53-6dot7_PE_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) PE (filled histogram) or rat IgG2a, κ PE isotype control (open histogram).
  • 2_53-67_PE_CD8a_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD8a (clone 53-6.7) PE (solid line) or rat IgG2a, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100707 50 µg NOK306
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100708 200 µg NOK883
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  2. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  3. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  4. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  5. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  6. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  7. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  8. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  9. Liu H, et al. 2022. Cancer Immunol Res. 10:1028. PubMed
  10. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  11. del Rio ML, et al. 2022. Front Immunol. 13:887348. PubMed
  12. Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed
  13. Zheng D, et al. 2023. Bioact Mater. 22:567. PubMed
  14. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  15. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  16. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  17. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  18. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  19. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  20. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  21. Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed
  22. Glaubitz J, et al. 2023. Gut. :. PubMed
  23. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  24. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  25. Takacs GP, et al. 2023. Front Immunol. 13:993444. PubMed
  26. Pan C, et al. 2022. Cell Mol Immunol. 19:516. PubMed
  27. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  28. He Y, et al. 2022. Adv Healthc Mater. 11:e2200905. PubMed
  29. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  30. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  31. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  32. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  33. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  34. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  35. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  36. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  37. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  38. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  39. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  40. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  41. Hao H, et al. 2023. Nat Biomed Eng. . PubMed
  42. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  43. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  44. del Rio ML, et al. 2023. Front Immunol. 14:1113858. PubMed
  45. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  46. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  47. Qin T, et al. 2023. Virol J. 20:75. PubMed
  48. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  49. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  50. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  51. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  52. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  53. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  54. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  55. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  56. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  57. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  58. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  59. Chen X, et al. 2009. Hum Immunol. 70:79. PubMed
  60. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed
  63. Sng XYX, et al. 2020. J Immunol. 204:3108. PubMed
  64. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  65. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  66. Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
  67. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  68. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  69. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  70. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  71. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  72. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  73. van Erp EA, et al. 2019. Viruses. 0.811111111. PubMed
  74. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  75. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  76. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  77. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  78. Diao L, et al. 2022. iScience. 25:105511. PubMed
  79. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  80. Ibrahim M, et al. 2016. J Evid Based Complementary Altern Med. 21: 171 - 176. PubMed
  81. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  82. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  83. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  84. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  85. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  86. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  87. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  88. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  89. N'guessan P, et al. 2011. Antioxid Redox Signal. 15:1693. PubMed
  90. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  91. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  92. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  93. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  94. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  95. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  96. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  97. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  98. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  99. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  100. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  101. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  102. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  103. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  104. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  105. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  106. Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed
  107. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  108. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  109. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  110. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  111. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  112. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  113. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  114. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  115. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  116. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  117. Li J, et al. 2019. JCI Insight. 5. PubMed
  118. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  119. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  120. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  121. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  122. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  123. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  124. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  125. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  126. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  127. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  128. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  129. Yang H, et al. 2022. Nutrients. 14:. PubMed
  130. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  131. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  132. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  133. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  134. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  135. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  136. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  137. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  138. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  139. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  140. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  141. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  142. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  143. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  144. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  145. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  146. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  147. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  148. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  149. Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed
  150. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  151. Cho K, et al. 2021. iScience. 24:103117. PubMed
  152. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  153. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  154. Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed
  155. Zhao X, et al. 2013. Int Immunopharmacol. 17:793. PubMed
  156. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  157. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  158. Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed
  159. Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed
  160. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  161. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  162. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  163. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  164. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  165. Manrique-Rincón A, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01150. PubMed
  166. Chan WF, et al. 2022. Nat Commun. 13:5582. PubMed
  167. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  168. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  169. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  170. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  171. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  172. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  173. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  174. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  175. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  176. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  177. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  178. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  179. Rodriguez-Sosa M, et al. 2004. Infect Immun. 72:4552. PubMed
  180. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  181. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  182. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  183. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  184. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  185. Bristow CL, et al. 2021. Front Oncol. 11:739080. PubMed
  186. Li J, et al. 2020. Development. :. PubMed
  187. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  188. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  189. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  190. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  191. Zhang J, et al. 2018. Nature. 553:91. PubMed
  192. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  193. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  194. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  195. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  196. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  197. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  198. Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed
  199. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  200. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  201. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  202. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  203. Pai M, et al. 2016. JPEN J Parenter Enteral Nutr. 40: 383 - 391. PubMed
  204. Koide S, et al. 2022. iScience. 25:103603. PubMed
  205. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  206. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  207. Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed
  208. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  209. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  210. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  211. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  212. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  213. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  214. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  215. Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed
  216. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  217. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  218. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  219. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  220. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  221. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  222. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  223. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
  224. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  225. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  226. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  227. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  228. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  229. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  230. Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed
  231. Chavez JS, et al. 2022. Cells. 11:. PubMed
  232. Wang X, et al. 2022. Elife. 11:. PubMed
  233. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  234. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  235. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  236. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  237. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  238. LeBlanc P, et al. 2014. J Biol Chem. 289:7777. PubMed
  239. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  240. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  241. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  242. Gawish R, et al. 2022. Elife. 11:. PubMed
  243. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  244. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  245. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  246. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  247. Zeng A, et al. 2020. Oncol Rep. . PubMed
  248. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  249. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  250. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  251. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  252. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  253. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  254. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  255. Lee YT, et al. 2018. PLoS One. 13:e0190868. PubMed
  256. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  257. Yang E, et al. 2015. Acta Biochim Biophys Sin. 47: 588-596. PubMed
  258. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  259. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  260. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  261. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  262. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  263. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  264. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  265. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  266. Liu H, et al. 2022. Cancer Immunol Res. 10:1028. PubMed
  267. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  268. del Rio ML, et al. 2022. Front Immunol. 13:887348. PubMed
  269. Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed
  270. Zheng D, et al. 2023. Bioact Mater. 22:567. PubMed
  271. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  272. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  273. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  274. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  275. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  276. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  277. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  278. Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed
  279. Glaubitz J, et al. 2023. Gut. :. PubMed
  280. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  281. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  282. Takacs GP, et al. 2023. Front Immunol. 13:993444. PubMed
  283. Pan C, et al. 2022. Cell Mol Immunol. 19:516. PubMed
  284. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  285. He Y, et al. 2022. Adv Healthc Mater. 11:e2200905. PubMed
  286. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  287. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  288. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  289. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  290. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  291. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  292. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  293. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  294. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  295. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  296. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  297. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  298. Hao H, et al. 2023. Nat Biomed Eng. . PubMed
  299. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  300. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  301. del Rio ML, et al. 2023. Front Immunol. 14:1113858. PubMed
  302. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  303. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  304. Qin T, et al. 2023. Virol J. 20:75. PubMed
  305. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  306. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  307. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  308. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  309. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  310. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  311. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  312. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  313. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  314. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  315. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  316. Chen X, et al. 2009. Hum Immunol. 70:79. PubMed
  317. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  318. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  319. Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed
  320. Sng XYX, et al. 2020. J Immunol. 204:3108. PubMed
  321. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  322. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  323. Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
  324. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  325. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  326. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  327. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  328. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  329. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  330. van Erp EA, et al. 2019. Viruses. 0.811111111. PubMed
  331. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  332. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  333. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  334. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  335. Diao L, et al. 2022. iScience. 25:105511. PubMed
  336. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  337. Ibrahim M, et al. 2016. J Evid Based Complementary Altern Med. 21: 171 - 176. PubMed
  338. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  339. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  340. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  341. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  342. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  343. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  344. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  345. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  346. N'guessan P, et al. 2011. Antioxid Redox Signal. 15:1693. PubMed
  347. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  348. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  349. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  350. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  351. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  352. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  353. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  354. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  355. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  356. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  357. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  358. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  359. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  360. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  361. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  362. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  363. Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed
  364. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  365. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  366. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  367. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  368. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  369. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  370. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  371. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  372. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  373. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  374. Li J, et al. 2019. JCI Insight. 5. PubMed
  375. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  376. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  377. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  378. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  379. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  380. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  381. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  382. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  383. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  384. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  385. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  386. Yang H, et al. 2022. Nutrients. 14:. PubMed
  387. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  388. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  389. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  390. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  391. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  392. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  393. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  394. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  395. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  396. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  397. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  398. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  399. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  400. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  401. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  402. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  403. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  404. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  405. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  406. Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed
  407. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  408. Cho K, et al. 2021. iScience. 24:103117. PubMed
  409. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  410. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  411. Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed
  412. Zhao X, et al. 2013. Int Immunopharmacol. 17:793. PubMed
  413. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  414. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  415. Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed
  416. Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed
  417. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  418. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  419. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  420. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  421. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  422. Manrique-Rincón A, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01150. PubMed
  423. Chan WF, et al. 2022. Nat Commun. 13:5582. PubMed
  424. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  425. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  426. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  427. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  428. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  429. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  430. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  431. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  432. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  433. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  434. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  435. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  436. Rodriguez-Sosa M, et al. 2004. Infect Immun. 72:4552. PubMed
  437. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  438. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  439. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  440. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  441. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  442. Bristow CL, et al. 2021. Front Oncol. 11:739080. PubMed
  443. Li J, et al. 2020. Development. :. PubMed
  444. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  445. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  446. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  447. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  448. Zhang J, et al. 2018. Nature. 553:91. PubMed
  449. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  450. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  451. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  452. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  453. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  454. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  455. Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed
  456. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  457. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  458. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  459. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  460. Pai M, et al. 2016. JPEN J Parenter Enteral Nutr. 40: 383 - 391. PubMed
  461. Koide S, et al. 2022. iScience. 25:103603. PubMed
  462. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  463. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  464. Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed
  465. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  466. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  467. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  468. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  469. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  470. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  471. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  472. Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed
  473. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  474. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  475. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  476. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  477. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  478. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  479. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  480. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
  481. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  482. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  483. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  484. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  485. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  486. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  487. Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed
  488. Chavez JS, et al. 2022. Cells. 11:. PubMed
  489. Wang X, et al. 2022. Elife. 11:. PubMed
  490. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  491. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  492. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  493. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  494. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  495. LeBlanc P, et al. 2014. J Biol Chem. 289:7777. PubMed
  496. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  497. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  498. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  499. Gawish R, et al. 2022. Elife. 11:. PubMed
  500. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  501. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  502. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  503. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  504. Zeng A, et al. 2020. Oncol Rep. . PubMed
  505. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  506. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  507. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  508. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  509. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  510. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  511. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  512. Lee YT, et al. 2018. PLoS One. 13:e0190868. PubMed
  513. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  514. Yang E, et al. 2015. Acta Biochim Biophys Sin. 47: 588-596. PubMed
RRID
AB_312746 (BioLegend Cat. No. 100707)
AB_312747 (BioLegend Cat. No. 100708)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
FITC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
APC anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01.21.2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
53-6.7 (See other available formats)
Regulatory Status
RUO
Other Names
T8, Lyt2, Ly-2
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_53-6dot7_PE_041106
C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) PE (filled histogram) or rat IgG2a, κ PE isotype control (open histogram).
  • 1_53-6dot7_PE_041106
    C57BL/6 mouse splenocytes were stained with CD8 (clone 53-6.7) PE (filled histogram) or rat IgG2a, κ PE isotype control (open histogram).
  • 2_53-67_PE_CD8a_Antibody_2_040122
    C57BL/6 mouse splenocytes were stained with CD8a (clone 53-6.7) PE (solid line) or rat IgG2a, κ PE isotype control (dashed line).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
100707 50 µg NOK306
Check Availability


Need larger quantities of this item?
Request Bulk Quote
100708 200 µg NOK883
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD8, also known as Lyt-2, Ly-2, or T8, consists of disulfide-linked α and β chains that form the α(CD8a)/β(CD8b) heterodimer and α/α homodimer. CD8a is a 34 kD protein that belongs to the immunoglobulin family. The CD8 α/β heterodimer is expressed on the surface of most thymocytes and a subset of mature TCR α/β T cells. CD8 expression on mature T cells is non-overlapping with CD4. The CD8 α/α homodimer is expressed on a subset of γ/δ TCR-bearing T cells, NK cells, intestinal intraepithelial lymphocytes, and lymphoid dendritic cells. CD8 is an antigen co-receptor on T cells that interacts with MHC class I on antigen-presenting cells or epithelial cells. CD8 promotes T cell activation through its association with the TCR complex and protein tyrosine kinase lck.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD8a antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 53-6.7 antibody competes with clone 5H10-1 antibody for binding to thymocytes3. The 53-6.7 antibody has been reported to block antigen presentation via MHC class I and inhibit T cell responses to IL-2. This antibody has also been used for depletion of CD8a+ cells. Additional reported applications (for the relevant formats) include: immunoprecipitation1,3, in vivo and in vitro cell depletion2,10,15, inhibition of CD8 T cell proliferation3, blocking of cytotoxicity3,4, immunohistochemical staining5,6 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, and spatial biology (IBEX)29,30. Clone 53-6.7 is not recommended for immunohistochemistry of formalin-fixed paraffin sections. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays or in vivo studies (Cat No. 100746).

Application References
  1. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IHC, IP)
  2. Hathcock KS. 1991. Current Protocols in Immunology. 3.4.1. (Deplete)
  3. Takahashi K, et al. 1992. P. Natl. Acad. Sci. USA 89:5557. (Block, IP)
  4. Ledbetter JA, et al. 1981. J. Exp. Med. 153:1503. (Block)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Fan WY, et al. 2001. Exp. Biol. Med. 226:1045. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Kamimura D, et al. 2006. J. Immunol. 177:306.
  9. Bouwer HGA, et al. 2006. P. Natl. Acad. Sci. USA 103:5102. (FC, Deplete)
  10. Kao C, et al. 2005. Int. Immunol. 17:1607. PubMed
  11. Ko SY, et al. 2005. J. Immunol. 175:3309. (FC) PubMed
  12. Rasmussen JW, et al. 2006. Infect. Immun. 74:6590. PubMed
  13. Lee CH, et al. 2009. Clin. Cancer Res. PubMed
  14. Geiben-Lynn R, et al. 2008. Blood 112:4585. (Deplete) PubMed
  15. Kingeter LM, et al. 2008. J. Immunol. 181:6244. PubMed
  16. Guo Y, et al. 2008. Blood 112:480. PubMed
  17. Andrews DM, et al. 2008. J. Virol. 82:4931. PubMed
  18. Britschqui MR, et al. 2008. J. Immunol. 181:7681. PubMed
  19. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  20. Jordan JM, et al. 2008. Infect. Immun. 76:3717. PubMed
  21. Todd DJ, et al. 2009. J. Exp. Med. 206:2151. PubMed
  22. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  23. Medyouf H, et al. 2010. Blood 115:1175. PubMed
  24. Riedl P, et al. 2009. J. Immunol. 183:370. PubMed
  25. Apte SH, et al. 2010. J. Immunol. 185:998. PubMed
  26. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  27. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  28. Cui L, et al. 2015. J Control Release. 206:220. PubMed
  29. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  30. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  2. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  3. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  4. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  5. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  6. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  7. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  8. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  9. Liu H, et al. 2022. Cancer Immunol Res. 10:1028. PubMed
  10. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  11. del Rio ML, et al. 2022. Front Immunol. 13:887348. PubMed
  12. Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed
  13. Zheng D, et al. 2023. Bioact Mater. 22:567. PubMed
  14. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  15. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  16. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  17. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  18. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  19. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  20. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  21. Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed
  22. Glaubitz J, et al. 2023. Gut. :. PubMed
  23. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  24. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  25. Takacs GP, et al. 2023. Front Immunol. 13:993444. PubMed
  26. Pan C, et al. 2022. Cell Mol Immunol. 19:516. PubMed
  27. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  28. He Y, et al. 2022. Adv Healthc Mater. 11:e2200905. PubMed
  29. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  30. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  31. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  32. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  33. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  34. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  35. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  36. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  37. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  38. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  39. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  40. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  41. Hao H, et al. 2023. Nat Biomed Eng. . PubMed
  42. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  43. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  44. del Rio ML, et al. 2023. Front Immunol. 14:1113858. PubMed
  45. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  46. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  47. Qin T, et al. 2023. Virol J. 20:75. PubMed
  48. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  49. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  50. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  51. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  52. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  53. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  54. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  55. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  56. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  57. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  58. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  59. Chen X, et al. 2009. Hum Immunol. 70:79. PubMed
  60. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  61. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  62. Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed
  63. Sng XYX, et al. 2020. J Immunol. 204:3108. PubMed
  64. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  65. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  66. Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
  67. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  68. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  69. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  70. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  71. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  72. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  73. van Erp EA, et al. 2019. Viruses. 0.811111111. PubMed
  74. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  75. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  76. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  77. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  78. Diao L, et al. 2022. iScience. 25:105511. PubMed
  79. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  80. Ibrahim M, et al. 2016. J Evid Based Complementary Altern Med. 21: 171 - 176. PubMed
  81. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  82. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  83. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  84. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  85. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  86. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  87. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  88. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  89. N'guessan P, et al. 2011. Antioxid Redox Signal. 15:1693. PubMed
  90. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  91. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  92. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  93. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  94. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  95. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  96. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  97. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  98. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  99. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  100. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  101. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  102. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  103. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  104. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  105. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  106. Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed
  107. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  108. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  109. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  110. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  111. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  112. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  113. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  114. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  115. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  116. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  117. Li J, et al. 2019. JCI Insight. 5. PubMed
  118. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  119. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  120. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  121. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  122. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  123. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  124. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  125. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  126. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  127. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  128. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  129. Yang H, et al. 2022. Nutrients. 14:. PubMed
  130. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  131. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  132. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  133. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  134. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  135. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  136. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  137. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  138. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  139. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  140. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  141. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  142. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  143. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  144. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  145. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  146. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  147. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  148. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  149. Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed
  150. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  151. Cho K, et al. 2021. iScience. 24:103117. PubMed
  152. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  153. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  154. Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed
  155. Zhao X, et al. 2013. Int Immunopharmacol. 17:793. PubMed
  156. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  157. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  158. Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed
  159. Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed
  160. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  161. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  162. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  163. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  164. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  165. Manrique-Rincón A, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01150. PubMed
  166. Chan WF, et al. 2022. Nat Commun. 13:5582. PubMed
  167. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  168. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  169. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  170. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  171. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  172. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  173. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  174. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  175. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  176. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  177. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  178. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  179. Rodriguez-Sosa M, et al. 2004. Infect Immun. 72:4552. PubMed
  180. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  181. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  182. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  183. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  184. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  185. Bristow CL, et al. 2021. Front Oncol. 11:739080. PubMed
  186. Li J, et al. 2020. Development. :. PubMed
  187. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  188. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  189. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  190. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  191. Zhang J, et al. 2018. Nature. 553:91. PubMed
  192. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  193. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  194. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  195. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  196. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  197. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  198. Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed
  199. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  200. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  201. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  202. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  203. Pai M, et al. 2016. JPEN J Parenter Enteral Nutr. 40: 383 - 391. PubMed
  204. Koide S, et al. 2022. iScience. 25:103603. PubMed
  205. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  206. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  207. Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed
  208. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  209. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  210. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  211. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  212. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  213. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  214. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  215. Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed
  216. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  217. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  218. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  219. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  220. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  221. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  222. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  223. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
  224. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  225. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  226. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  227. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  228. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  229. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  230. Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed
  231. Chavez JS, et al. 2022. Cells. 11:. PubMed
  232. Wang X, et al. 2022. Elife. 11:. PubMed
  233. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  234. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  235. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  236. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  237. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  238. LeBlanc P, et al. 2014. J Biol Chem. 289:7777. PubMed
  239. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  240. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  241. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  242. Gawish R, et al. 2022. Elife. 11:. PubMed
  243. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  244. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  245. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  246. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  247. Zeng A, et al. 2020. Oncol Rep. . PubMed
  248. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  249. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  250. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  251. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  252. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  253. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  254. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  255. Lee YT, et al. 2018. PLoS One. 13:e0190868. PubMed
  256. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  257. Yang E, et al. 2015. Acta Biochim Biophys Sin. 47: 588-596. PubMed
  258. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  259. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  260. Sun L, et al. 2021. Cancer Cell. 39:1361. PubMed
  261. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  262. Xu C, et al. 2017. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2017.05.071. PubMed
  263. Thomas R, et al. 2021. Immunology. 163:478. PubMed
  264. Xue G, et al. 2021. Cancer Cell. 39:1610. PubMed
  265. Zveik O, et al. 2022. Glia. 70:1191. PubMed
  266. Liu H, et al. 2022. Cancer Immunol Res. 10:1028. PubMed
  267. Silva Pereira S, et al. 2022. Elife. 11: . PubMed
  268. del Rio ML, et al. 2022. Front Immunol. 13:887348. PubMed
  269. Lin G, et al. 2022. Int J Immunopathol Pharmacol. 36:3946320221117933. PubMed
  270. Zheng D, et al. 2023. Bioact Mater. 22:567. PubMed
  271. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  272. He Y, et al. 2022. Front Immunol. 13:986202. PubMed
  273. Hao J, et al. 2022. Cell Rep. 41:111804. PubMed
  274. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  275. Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed
  276. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  277. Kumpunya S, et al. 2023. Front Immunol. 13:1010764. PubMed
  278. Huseni MA, et al. 2023. Cell Rep Med. 4:100878. PubMed
  279. Glaubitz J, et al. 2023. Gut. :. PubMed
  280. Lin J, et al. 2023. Nat Commun. 14:224. PubMed
  281. Lu T, et al. 2023. Cancer Immunol Immunother. :. PubMed
  282. Takacs GP, et al. 2023. Front Immunol. 13:993444. PubMed
  283. Pan C, et al. 2022. Cell Mol Immunol. 19:516. PubMed
  284. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  285. He Y, et al. 2022. Adv Healthc Mater. 11:e2200905. PubMed
  286. Sugitani N, et al. 2022. Cell Rep. 40:111371. PubMed
  287. Shi X, et al. 2022. Proc Natl Acad Sci U S A. 119:e2208506119. PubMed
  288. Zhu C, et al. 2022. Chemotherapy. 67:211. PubMed
  289. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  290. Sparbier CE, et al. 2023. Nat Cell Biol. 25:258. PubMed
  291. Swan SL, et al. 2023. Front Immunol. 14:1085547. PubMed
  292. Wang F, et al. 2023. Int J Mol Sci. 24:. PubMed
  293. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  294. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  295. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  296. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  297. Tang C, et al. 2023. Nat Commun. 14:1493. PubMed
  298. Hao H, et al. 2023. Nat Biomed Eng. . PubMed
  299. Tao Q, et al. 2023. Microbiol Spectr. :e0522922. PubMed
  300. Fukuzaki Y, et al. 2023. iScience. 26:106340. PubMed
  301. del Rio ML, et al. 2023. Front Immunol. 14:1113858. PubMed
  302. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  303. Fu S, et al. 2023. Nat Commun. 14:2248. PubMed
  304. Qin T, et al. 2023. Virol J. 20:75. PubMed
  305. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  306. Oh J, et al. 2023. Nat Commun. 14:3278. PubMed
  307. Ye S, et al. 2023. Front Oncol. 13:1202750. PubMed
  308. Zelenka T, et al. 2022. Nat Commun. 13:6954. PubMed
  309. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  310. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  311. Wu SY, et al. 2022. Mol Cancer. 21:84. PubMed
  312. Lee S, et al. 2021. JCI Insight. 6:. PubMed
  313. Manukian G, et al. 2021. Int J Radiat Oncol Biol Phys. 110:1341. PubMed
  314. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  315. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  316. Chen X, et al. 2009. Hum Immunol. 70:79. PubMed
  317. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  318. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  319. Qin Y, et al. 2021. Cell Rep. 37:109968. PubMed
  320. Sng XYX, et al. 2020. J Immunol. 204:3108. PubMed
  321. Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed
  322. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  323. Kagoya Y, et al. 2018. Nat Commun. 9:1915. PubMed
  324. Misumi I et al. 2019. Cell Rep. 27(5):1387-1396 . PubMed
  325. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  326. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  327. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  328. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  329. Zhao B, et al. 2020. Nat Commun. 11:908. PubMed
  330. van Erp EA, et al. 2019. Viruses. 0.811111111. PubMed
  331. Ren J, et al. 2021. Theranostics. 11:304. PubMed
  332. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  333. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  334. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  335. Diao L, et al. 2022. iScience. 25:105511. PubMed
  336. Wong J, et al. 2015. Elife. 3: 07839. PubMed
  337. Ibrahim M, et al. 2016. J Evid Based Complementary Altern Med. 21: 171 - 176. PubMed
  338. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  339. Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed
  340. Chaurasiya S, et al. 2020. Oncoimmunology. 9:1729300. PubMed
  341. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  342. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  343. Misumi I et al. 2019. Cell Rep. 27(2):514-524 . PubMed
  344. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  345. Tian X, et al. 2022. Front Immunol. 13:875236. PubMed
  346. N'guessan P, et al. 2011. Antioxid Redox Signal. 15:1693. PubMed
  347. Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
  348. Felker A, Croy B 2016. J Leukoc Biol. 100: 645 - 655. PubMed
  349. Lo W, Allen D 2012. Nat Immunol. 13:880. PubMed
  350. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  351. Rana A, et al. 2020. Front Immunol. 11:536. PubMed
  352. Uchida A, et al. 2021. J Inflamm Res. 14:3089. PubMed
  353. Jia L, et al. 2022. Front Immunol. 13:897879. PubMed
  354. Li H, et al. 2021. Nat Commun. 12:2773. PubMed
  355. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  356. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  357. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  358. Morabito KM, et al. 2017. Mucosal Immunol. 0.795138889. PubMed
  359. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  360. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  361. Sharma S, et al. 2015. J Immunol. 194:5529. PubMed
  362. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  363. Meyer LK, et al. 2019. J Clin Invest. 130:863. PubMed
  364. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  365. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  366. Edwards CJ, et al. 2021. Br J Cancer. . PubMed
  367. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  368. Wang B, et al. 2022. Nat Commun. 13:3821. PubMed
  369. Ebina-Shibuya R, et al. 2021. Elife. 10:. PubMed
  370. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  371. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  372. Wei JL, et al. 2021. J Immunother Cancer. 9: . PubMed
  373. Perry JSA, et al. 2018. Immunity. 48:923. PubMed
  374. Li J, et al. 2019. JCI Insight. 5. PubMed
  375. Li H, et al. 2022. Theranostics. 12:6422. PubMed
  376. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  377. Hu G, et al. 2022. Cell Death Dis. 13:640. PubMed
  378. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  379. Naing A et al. 2019. Cell reports. 26(5):1242-1257 . PubMed
  380. Yang R, et al. 2022. Front Pharmacol. 13:774440. PubMed
  381. Burrack K, et al. 2015. PLoS Pathog. 11: e1005191. PubMed
  382. Paul S, et al. 2018. Appl Microbiol Biotechnol. 102:8895. PubMed
  383. Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
  384. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  385. Zhong W, et al. 2022. Nat Commun. 13:4390. PubMed
  386. Yang H, et al. 2022. Nutrients. 14:. PubMed
  387. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  388. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  389. Wang Y, et al. 2021. Front Immunol. 12:654463. PubMed
  390. Lu Y, et al. 2021. Gastroenterology. 161:575. PubMed
  391. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  392. Zhang W, et al. 2019. Oncol Lett. 17:815. PubMed
  393. Lee CG, et al. 2019. JCI Insight. 4:5. PubMed
  394. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  395. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  396. Parhi L, et al. 2020. Nat Commun. 2.721527778. PubMed
  397. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  398. Pilones KA, et al. 2020. Cancer Immunol Res. 8:1054. PubMed
  399. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  400. Becher J, et al. 2018. Dev Cell. 47:592. PubMed
  401. van Montfoort N, et al. 2018. Cell. 175:1744. PubMed
  402. Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
  403. Sido J, et al. 2015. J Leukoc Biol. 98: 435-447. PubMed
  404. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  405. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  406. Loh Z, et al. 2020. PLOS Pathogens. 16(7):e1008651. PubMed
  407. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  408. Cho K, et al. 2021. iScience. 24:103117. PubMed
  409. Sun C, et al. 2022. J Adv Res. 35:71. PubMed
  410. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  411. Guo C, et al. 2017. Methods Mol Biol. 1709:345. PubMed
  412. Zhao X, et al. 2013. Int Immunopharmacol. 17:793. PubMed
  413. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  414. Schuldt N, et al. 2015. PLoS One. 10: 0145762. PubMed
  415. Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed
  416. Moutuou MM, et al. 2020. Methods Mol Biol. 2111:267. PubMed
  417. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  418. Anderson AE, et al. 2022. NPJ Regen Med. 7:6. PubMed
  419. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  420. Bates PD, et al. 2021. Front Immunol. 12:668307. PubMed
  421. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  422. Manrique-Rincón A, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01150. PubMed
  423. Chan WF, et al. 2022. Nat Commun. 13:5582. PubMed
  424. Chou T, et al. 2016. Nat Commun. 7:11904. PubMed
  425. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  426. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  427. Schreiber K, et al. 2020. Cancer Immunol Res. 8:192. PubMed
  428. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  429. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  430. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  431. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  432. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  433. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  434. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  435. Kmieciak M, et al. 2011. J Vis Exp. 47: 2381. PubMed
  436. Rodriguez-Sosa M, et al. 2004. Infect Immun. 72:4552. PubMed
  437. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  438. Wong YC, et al. 2019. J Virol. 93:e01154-19. PubMed
  439. Shen DD, et al. 2022. Mol Cancer. 21:75. PubMed
  440. Zhu J, et al. 2021. Cancer Cell Int. 21:529. PubMed
  441. Baranwal G, et al. 2021. Physiol Rep. 9:e15094. PubMed
  442. Bristow CL, et al. 2021. Front Oncol. 11:739080. PubMed
  443. Li J, et al. 2020. Development. :. PubMed
  444. Liu Y, et al. 2020. Oncol Lett. 2369:20. PubMed
  445. Li J, et al. 2020. FASEB J. 34:3091. PubMed
  446. Cai Z, et al. 2020. Cell Rep. 31:107816. PubMed
  447. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  448. Zhang J, et al. 2018. Nature. 553:91. PubMed
  449. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  450. Kim DK, et al. 2022. Nat Commun. 13:6292. PubMed
  451. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  452. Kovacs SB, et al. 2021. STAR Protoc. 2:100244. PubMed
  453. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  454. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
  455. Tsai SJ, et al. 2021. J Biol Chem. 297:101266. PubMed
  456. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  457. Eisemann T, et al. 2019. Front Oncol. 9:187. PubMed
  458. Chen X, et al. 2019. Med Sci Monit. 25:5389. PubMed
  459. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  460. Pai M, et al. 2016. JPEN J Parenter Enteral Nutr. 40: 383 - 391. PubMed
  461. Koide S, et al. 2022. iScience. 25:103603. PubMed
  462. Kline JM, et al. 2021. J Biol Chem. :100373. PubMed
  463. Yang Z, et al. 2021. Nat Commun. 12:4299. PubMed
  464. Ene CI, et al. 2020. Neuro Oncol. 639:22. PubMed
  465. Si J, et al. 2020. Cancer Cell. 38(4):551-566.e11. PubMed
  466. Xu C, et al. 2020. Immunity. 53(2):417-428.e4. PubMed
  467. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  468. Liu Y, et al. 2018. Cancer Cell. 33:480. PubMed
  469. Flesch I, et al. 2015. J Immunol. 195: 2263-2272. PubMed
  470. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  471. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  472. Wu G, et al. 2021. Nat Cancer. 2:1170. PubMed
  473. Fedele C, et al. 2021. J Exp Med. 218: . PubMed
  474. Rodríguez L, et al. 2021. Biomolecules. 11: . PubMed
  475. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  476. Jia H, et al. 2018. Int J Oncol. 53:949. PubMed
  477. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  478. Yang N, et al. 2022. Nat Commun. 13:2336. PubMed
  479. Schnoegl D, et al. 2022. Front Immunol. 13:909270. PubMed
  480. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
  481. Zhu E, et al. 2014. J Immunol. 192:5599. PubMed
  482. Wu Y, et al. 2015. J Immunol. 195: 2612-2623. PubMed
  483. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  484. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  485. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  486. Barsoumian HB, et al. 2022. Cancers (Basel). 14:. PubMed
  487. Lin J, et al. 2021. Cancer Immunol Res. 9:1413. PubMed
  488. Chavez JS, et al. 2022. Cells. 11:. PubMed
  489. Wang X, et al. 2022. Elife. 11:. PubMed
  490. Wang F, et al. 2021. Neoplasia. 23:281. PubMed
  491. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  492. Bonavita E, et al. 2020. Immunity. 1215:53. PubMed
  493. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  494. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  495. LeBlanc P, et al. 2014. J Biol Chem. 289:7777. PubMed
  496. Chen R, et al. 2021. Front Oncol. 11:743050. PubMed
  497. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  498. Zhang M, et al. 2022. iScience. 25:104490. PubMed
  499. Gawish R, et al. 2022. Elife. 11:. PubMed
  500. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  501. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  502. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  503. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  504. Zeng A, et al. 2020. Oncol Rep. . PubMed
  505. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  506. Angela M, et al. 2016. Nat Commun. 7:13683. PubMed
  507. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  508. Pastor Arroyo EM, et al. 2022. Clin Sci (Lond). 136:557. PubMed
  509. Shi GN, et al. 2021. Ther Adv Med Oncol. 13:1758835920987056. PubMed
  510. Lv K, et al. 2021. Cell Stem Cell. 28(7):1275-1290.e9. PubMed
  511. Zhou T, et al. 2018. Mol Med Rep. 17:4883. PubMed
  512. Lee YT, et al. 2018. PLoS One. 13:e0190868. PubMed
  513. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  514. Yang E, et al. 2015. Acta Biochim Biophys Sin. 47: 588-596. PubMed
RRID
AB_312746 (BioLegend Cat. No. 100707)
AB_312747 (BioLegend Cat. No. 100708)

Antigen Details

Structure
Ig superfamily, CD8α chain, 34 kD
Distribution

Most thymocytes, T cell subset, some NK cells, lymphoid dendritic cells

Function
Co-receptor for TCR
Ligand/Receptor
MHC class I molecule
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Zamoyska R. 1994. Immunity 1:243.
3. Ellmeier W, et al. 1999. Annu. Rev. Immunol. 17:523.

Gene ID
12525 View all products for this Gene ID
UniProt
View information about CD8alpha on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD8a Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC-F,IP
PE/Cyanine5 anti-mouse CD8a 53-6.7 FC
PE anti-mouse CD8a 53-6.7 FC
FITC anti-mouse CD8a 53-6.7 FC
Biotin anti-mouse CD8a 53-6.7 FC,IHC
APC anti-mouse CD8a 53-6.7 FC
PE/Cyanine7 anti-mouse CD8a 53-6.7 FC
PE/Dazzle™ 594 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 750 anti-mouse CD8a 53-6.7 FC
GoInVivo™ Purified anti-mouse CD8a 53-6.7 FC
TotalSeq™-A0002 anti-mouse CD8a 53-6.7 PG
Spark NIR™ 685 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 550 anti-mouse CD8a 53-6.7 FC
TotalSeq™-C0002 anti-mouse CD8a 53-6.7 PG
TotalSeq™-B0002 anti-mouse CD8a 53-6.7 PG
Spark YG™ 570 anti-mouse CD8a 53-6.7 IHC-F
PE/Fire™ 640 anti-mouse CD8a 53-6.7 FC
PE/Fire™ 700 anti-mouse CD8a 53-6.7 FC
APC/Cyanine7 anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 488 anti-mouse CD8a 53-6.7 FC,3D IHC
Alexa Fluor® 647 anti-mouse CD8a 53-6.7 FC,IHC-F,3D IHC,SB
Pacific Blue™ anti-mouse CD8a 53-6.7 FC
Alexa Fluor® 700 anti-mouse CD8a 53-6.7 FC
PerCP/Cyanine5.5 anti-mouse CD8a 53-6.7 FC
PerCP anti-mouse CD8a 53-6.7 FC
Brilliant Violet 421™ anti-mouse CD8a 53-6.7 FC,IHC,SB
Brilliant Violet 570™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 650™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 605™ anti-mouse CD8a 53-6.7 FC
Ultra-LEAF™ Purified anti-mouse CD8a 53-6.7 FC,CyTOF®,IHC,IP,Depletion,Block
Brilliant Violet 711™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 785™ anti-mouse CD8a 53-6.7 FC
Brilliant Violet 510™ anti-mouse CD8a 53-6.7 FC
Purified anti-mouse CD8a (Maxpar® Ready) 53-6.7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse CD8a 53-6.7 IHC-F,FC,3D IHC
Spark Blue™ 574 anti-mouse CD8a Antibody 53-6.7 FC
Spark Violet™ 423 anti-mouse CD8a Antibody 53-6.7 FC
Spark UV™ 387 anti-mouse CD8a 53-6.7 FC
Spark Blue™ 515 anti-mouse CD8a 53-6.7 FC
APC/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark Red™ 718 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
PE/Fire™ 810 anti-mouse CD8a 53-6.7 FC
Spark PLUS UV395™ anti-mouse CD8a 53-6.7 FC
PerCP/Fire™ 780 anti-mouse CD8a 53-6.7 FC
Spark YG™ 581 anti-mouse CD8a (Flexi-Fluor™) 53-6.7 FC
Spark YG™ 593 anti-mouse CD8a (Flexi-Fluor™) Antibody 53-6.7 FC
StarBright UltraViolet 575 anti-mouse CD8a 53-6.7 FC
Spark PLUS V475™ anti-mouse CD8a 53-6.7 FC
StarBright UltraViolet 795 anti-mouse CD8a 53-6.7 FC
Go To Top Version: 2    Revision Date: 01.21.2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account